Earlier in May, several states reported a shortage of Remdesivir with relatives of COVID-19 patients waiting in long queues for several hours for the drug.
The Union government has halted the allocation of the antiviral drug Remdesivir to states because the supply of the drug exceeded demand, Union Minister Mansukh L Mandaviya said on Saturday. “Now the country has enough #Remdesivir because the supply is much higher than the demand. So we have decided to STOP the central allocation of Remdesivir to the states,” Mandaviya said in a tweet.
The Minister of State for Chemicals and Fertilizers noted that the supply of the drug, which is used to treat COVID-19, has been increased more than tenfold, from just 33,000 vials per day on April 11, 2021 to 350,000 vials per day currently. The government has also increased the number of factories producing Remdesivir from just 20 to 60 factories in a month, he added.
In addition, the Union government decided to procure 50 lakh vials of Remdesivir to maintain it as a strategic stockpile for emergency needs, Mandaviya said. “But I also asked @nppa_india & @CDSCO_INDIA_INF to continuously monitor the availability of Remdesivir in the country,” he noted. The Union government’s decision also comes at a time when several cases are seeing a drop in COVID-19 cases.
In order to improve supply, the government had previously removed tariffs on Remdesivir, its raw materials and other components used in the manufacture of the antiviral drug to help increase domestic availability and reduce the cost of the drug. ‘injection. On April 11, in view of the increased demand for Remdesivir, the Union government banned the export of the injection and its active pharmaceutical ingredients (APIs) until the situation improved. Various pharmaceutical companies have also reduced the prices of Remdesivir injection following government intervention.
Earlier in May, several states reported a shortage of Remdesivir with relatives of COVID-19 patients waiting in long queues for several hours for the drug. This despite several experts stressing that it is not a miracle or life-saving drug. In fact, several studies, including the World Health Organization solidarity trial, have shown that it is not effective in treating COVID-19 patients. Although the WHO advises against the use of Remdesivir for COVID-19 patients, India has yet to withdraw the drug from its COVID-19 treatment protocol.
With PTI inputs